Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Oxytosis/Ferroptosis in Neurodegeneration: the Underlying Role of Master Regulator Glutathione Peroxidase 4 (GPX4)
Nawab John Dar, Urmilla John, Nargis Bano, et al.
Molecular Neurobiology (2023) Vol. 61, Iss. 3, pp. 1507-1526
Closed Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

GPX4, ferroptosis, and diseases
Wangzheqi Zhang, Yang Liu, Liao Yan, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 174, pp. 116512-116512
Open Access | Times Cited: 58
Iron homeostasis and ferroptosis in human diseases: mechanisms and therapeutic prospects
Qin Ru, Yusheng Li, Lin Chen, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 56
Ferroptosis inhibitors: past, present and future
Lei Zhang, Yi Luo, Yang Xiang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 17
Iron toxicity, ferroptosis and microbiota in Parkinson’s disease: Implications for novel targets
Fernanda V. Carvalho, Harold E. Landis, Bruk Getachew, et al.
Advances in neurotoxicology (2024), pp. 105-132
Open Access | Times Cited: 9
Neuroinflammation and Neurodegenerative Diseases: How Much Do We Still Not Know?
Carmela Rita Balistreri, Roberto Monastero
Brain Sciences (2023) Vol. 14, Iss. 1, pp. 19-19
Open Access | Times Cited: 20
Mechanisms of chondrocyte cell death in osteoarthritis: implications for disease progression and treatment
Mengqi Guan, Qingyuan Yu, Guohui Zhou, et al.
Journal of Orthopaedic Surgery and Research (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 6
Mechanisms and therapeutic targets of ferroptosis: Implications for nanomedicine design
Meihong Zhang, Mengqin Guo, Yue Gao, et al.
Journal of Pharmaceutical Analysis (2024) Vol. 14, Iss. 7, pp. 100960-100960
Open Access | Times Cited: 4
LINC00472 Regulates Ferroptosis of Neurons in Alzheimer’s Disease via FOXO1
Ping Lin, Jiandong Wang, Yuyan Li, et al.
Dementia and Geriatric Cognitive Disorders (2024) Vol. 53, Iss. 3, pp. 107-118
Closed Access | Times Cited: 4
Propofol ameliorates cognitive deficits following splenectomy in aged rats by inhibiting ferroptosis via the SIRT1/Nrf2/GPX4 pathway
Yadong Wen, Weihua Zhang, Dingran Wang, et al.
Neuroreport (2024) Vol. 35, Iss. 13, pp. 846-856
Closed Access | Times Cited: 4
Ferroptosis in Endometriosis: Traditional Chinese Medicine Interventions and Mechanistic Insights
Dazhi Lan, Shuping Huang, Jing Li, et al.
The American Journal of Chinese Medicine (2025), pp. 1-24
Closed Access
Betulinic acid protects against lipopolysaccharide and ferrous sulfate-induced oxidative stress, ferroptosis, apoptosis, and neuroinflammation signaling relevant to Parkinson's Disease
Shivam Kumar Pandey, Anjuman Nanda, Avtar Singh Gautam, et al.
Free Radical Biology and Medicine (2025)
Closed Access
Novel insights into the role of ferroptosis in temporomandibular joint osteoarthritis and knee osteoarthritis
Yuxin Zhang, Dahe Zhang, Xiaoyu Liao, et al.
International Journal of Medical Sciences (2025) Vol. 22, Iss. 9, pp. 2119-2131
Open Access
Danggui Shaoyao San ameliorates Alzheimer’s disease by regulating lipid metabolism and inhibiting neuronal ferroptosis through the AMPK/Sp1/ACSL4 signaling pathway
Kai Gong, Shuang Zhou, Xiao Li, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Ferroptosis and Iron Homeostasis: Molecular Mechanisms and Neurodegenerative Disease Implications
Nurzhan Abdukarimov, Kamilya Kokabi, Jeannette Kunz
Antioxidants (2025) Vol. 14, Iss. 5, pp. 527-527
Open Access
PPT1 Promotes Growth and Inhibits Ferroptosis of Oral Squamous Cell Carcinoma Cells
Qingqiong Luo, Sheng Hu, Yijie Tang, et al.
Current Cancer Drug Targets (2024) Vol. 24, Iss. 10, pp. 1047-1060
Closed Access | Times Cited: 3
Excitotoxicity, Oxytosis/Ferroptosis, and Neurodegeneration: Emerging Insights into Mitochondrial Mechanisms
Sameera Khan, Nargis Bano, Shakir Ahamad, et al.
Aging and Disease (2024)
Open Access | Times Cited: 3
Iron Homeostasis and Neurodegeneration in the Aging Brain: Insight into Ferroptosis Pathways
Mohammed Alrouji, Saleha Anwar, Kumar Venkatesan, et al.
Ageing Research Reviews (2024) Vol. 102, pp. 102575-102575
Closed Access | Times Cited: 3
Ferroptosis and Cognitive Impairment: Unraveling the Link and Potential Therapeutic Targets
Soudabeh Naderi, Fariba Khodagholi, Mahyar Janahmadi, et al.
Neuropharmacology (2024) Vol. 263, pp. 110210-110210
Closed Access | Times Cited: 3
Neuroinflammation and Neurodegenerative Diseases: How Much Do We Still Not Know?
Carmela Rita Balistreri, Roberto Monastero
(2023)
Open Access | Times Cited: 8
Research trends of ferroptosis and pyroptosis in Parkinson’s disease: a bibliometric analysis
Tzu-Hua Wu, Kexin Zhong, Biao Tang, et al.
Frontiers in Molecular Neuroscience (2024) Vol. 17
Open Access | Times Cited: 2
The Biological Activity of Ganoderma lucidum on Neurodegenerative Diseases: The Interplay between Different Active Compounds and the Pathological Hallmarks
Wenhui Lian, Xu Yang, Qidong Duan, et al.
Molecules (2024) Vol. 29, Iss. 11, pp. 2516-2516
Open Access | Times Cited: 2
Targeting ferroptosis opens new avenues in gliomas
Yuxin Wei, Yang Xu, Qian Sun, et al.
International Journal of Biological Sciences (2024) Vol. 20, Iss. 12, pp. 4674-4690
Open Access | Times Cited: 2
Increased spontaneous activity and progressive suppression of adult neurogenesis in the hippocampus of rat offspring after maternal exposure to imidacloprid
Xinyu Zou, Qian Tang, Ryota Ojiro, et al.
Chemico-Biological Interactions (2024) Vol. 399, pp. 111145-111145
Open Access | Times Cited: 1
Severe Neurodevelopmental Phenotype, Diagnostic and Treatment Challenges in Patients with SECISBP2 Deficiency
Athanasia Stoupa, Mônica M. França, Maha Abdulhadi‐Atwan, et al.
Genetics in Medicine (2024) Vol. 26, Iss. 12, pp. 101280-101280
Open Access | Times Cited: 1
Gene therapy for Parkinson’s Disease and Ethical Challenges: A Systematic Review
Théodora Mahoukèdè Zohoncon, Joseph Sawadogo, Abdou Azaque Zouré, et al.
Advances in Parkinson s Disease (2023) Vol. 12, Iss. 02, pp. 9-28
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top